Zometa intravenous infusion 4mg/100mL, manufactured by Novartis Pharma, contains Zoledronic acid hydrate. This injectable drug, with YJ code 3999423A2024 and standard 4mg 100mL 1 bottle, is a ready-to-use solution for preventing skeletal-related events in advanced malignancies involving bone and treating hypercalcemia of malignancy.
Zometa intravenous infusion 4mg/100mL
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →